COVID-19 pandemic: Its impact on liver disease and liver transplantation

Table 1 The summary of the clinical studies about acute liver injury in coronavirus infectious disease-2019

Ref.	Total patients	No. of ALI, n (%)	No. of severe disease among ALI, n (%)	Number of dismal prognosis among ALI, n (%)
Zhou et al[4]	191	59 (38.8)	NS	26 (44.1)
Huang et al[24]	41	15 (36.6)	8 (53.3)	NS
Guan et al[41]	1099	326 (29.7)	94 (28.8)	46 (14.1)
Hu et al[43]	323	265 (82)	134 (50.6)	58 (21.9)
Zhang et al[45]	115	28 (24.3)	20 (71.4)	NS
Yang et al[44]	149	45 (30.2)	NS	NS
Fu et al[46]	350	101 (28.8)	NS	14 (13.9)
Cai et al[47]	298	44 (14.7)	21 (47.7)	NS
Cao et al[48]1	199	120 (60.3)	NS	NS
Shi et al[49]	81	43 (53.1)	26 (83.7)	NS
Omrani-Nava et al[50]	93	27 (29.2)	NS	NS

It was considered acute liver injury if the patients had elevated alanine aminotransferase, aspartate aminotransferase, or both or if acute liver injury is reported by the authors.

¹All were severe cases. ALI: Acute liver injury; No.: Number of individuals dismal prognosis: progression of the disease despite suitable therapy of occurrence of mortality in the patients; NS: Not specified.